Skip to main content
Top
Published in: Journal of Translational Medicine 1/2012

Open Access 01-12-2012 | Research

Validation of a single-platform, volumetric, flow cytometry for CD4 T cell count monitoring in therapeutic mobile unit

Authors: François-Xavier Mbopi-Kéou, Bertrand Sagnia, Jeanne Ngogang, Fru F Angwafo III, Vittorio Colizzi, Luc Montagnier, Laurent Bélec

Published in: Journal of Translational Medicine | Issue 1/2012

Login to get access

Abstract

Background

A mobile health unit may be useful to follow up adult and pediatric patients on antiretroviral treatment and living in remote areas devoid of laboratory facilities. The study evaluated the use of the simplified, robust, single-plateform, volumetric, pan-leucogating Auto40 flow cytometer (Apogee Flow Systems Ltd, Hemel Hempstead, UK) for CD4 T cell numeration in a mobile unit, compared against a reference flow cytometry method.

Methods

The therapeutic mobile unit of the Laboratoire National de Santé Hygiène Mobile, Yaoundé, Cameroon, was equipped with the Auto40. A FACSCalibur flow cytometer (Becton Dickinson Immuno-cytometry System, San Jose, CA, USA) was used as reference method. EDTA-blood samples from volunteers were first subjected to CD4 T cell count in the mobile unit, and an aliquot was sent within 4 hours to Centre International de Référence Chantal Biya, Yaoundé, for FACSCalibur assay.

Results

Two HIV screening campaigns with the mobile unit were organised in December 2009 and January 2010. The campaign in the suburb of Yaoundé which was 20 km from the reference laboratory included 188 volunteers comprising 93 children less than 5 years old. The campaign in Ambang Bikok (53 km far from Yaoundé) included 69 adult volunteers. In Yaoundé suburb, mean ± standard deviation (SD) CD4 T cell count was 996 ± 874 cells/μl by Auto40, and 989 ± 883 cells/μl by FACSCalibur; in Ambang Bikok, mean ± SD CD4 T cell count was 1041 ± 317 cells/μl by Auto40, and 1032 ± 294 cells/μl by FACSCalibur. Results by Auto40 and FACSCalibur were highly correlated in Yaoundé (r2 = 0.982) as in Ambang Bikok (r2 = 0.921). Bland-Altman analysis showed a close agreement between Auto40 and FACSCalibur results expressed in absolute count as in percentage in Yaoundé and Ambang Bikok. When pooling the 257 CD4 T cell count measurements, the Auto40 yielded a mean difference of +7.6 CD4 T cells/μl higher than by reference flow cytometry; and the sensitivity and specificity of Auto40 in enumerating absolute CD4 T cell counts of less than 200 cells/μl were 87% and 99%, respectively, and in enumerating absolute CD4 T cell counts of less than 350 cells/μl were 87% and 98%, respectively. The intrarun and interun precisions of the Auto40 assay assessed in the mobile unit were 5.5% and 7.9%, respectively.

Conclusions

The Auto40 flow cytometer installed in a therapeutic mobile unit and operated far from its reference laboratory gave a perfect correlation with the reference method, and could be useful in carrying out immunological monitoring of HIV-infected patients living in areas without access to laboratory facilities.
Appendix
Available only for authorised users
Literature
3.
go back to reference Bélec L, Bonn JP: Challenges in implementing HIV laboratory monitoring in resource-constrained settings: how to do more with less. Future Microbiol. 2011, 6: 1251-1260. 10.2217/fmb.11.121.CrossRefPubMed Bélec L, Bonn JP: Challenges in implementing HIV laboratory monitoring in resource-constrained settings: how to do more with less. Future Microbiol. 2011, 6: 1251-1260. 10.2217/fmb.11.121.CrossRefPubMed
7.
go back to reference Mandy F, Nicholson J, McDougal J, CDC: Guidelines for performing single-platform absolute CD4R T-cell determinations with CD45 gating for persons infected with human immunodeficiency virus. Centers for Disease Control and Prevention. MMWR Recomm Rep. 2003, 52 (RR-2): 1-13.PubMed Mandy F, Nicholson J, McDougal J, CDC: Guidelines for performing single-platform absolute CD4R T-cell determinations with CD45 gating for persons infected with human immunodeficiency virus. Centers for Disease Control and Prevention. MMWR Recomm Rep. 2003, 52 (RR-2): 1-13.PubMed
8.
go back to reference Dieye TN, Vereecken C, Diallo AA, Ondoa P, Diaw PA, Camara M, Karam F, Mboup S, Kestens L: Absolute CD4 T-cell counting in resource-poor settings: direct volumetric measurements versus bead-based clinical flow cytometry instruments. J Acquir Immune Defic Syndr. 2005, 39: 32-37. 10.1097/01.qai.0000160515.20581.ad.CrossRefPubMed Dieye TN, Vereecken C, Diallo AA, Ondoa P, Diaw PA, Camara M, Karam F, Mboup S, Kestens L: Absolute CD4 T-cell counting in resource-poor settings: direct volumetric measurements versus bead-based clinical flow cytometry instruments. J Acquir Immune Defic Syndr. 2005, 39: 32-37. 10.1097/01.qai.0000160515.20581.ad.CrossRefPubMed
9.
go back to reference O'Gorman MR, Zijenah LS: CD4 T cell measurements in the management of antiretroviral therapy--a review with an emphasis on pediatric HIV-infected patients. Cytometry B Clin Cytom. 2008, 74: S19-S26.CrossRefPubMed O'Gorman MR, Zijenah LS: CD4 T cell measurements in the management of antiretroviral therapy--a review with an emphasis on pediatric HIV-infected patients. Cytometry B Clin Cytom. 2008, 74: S19-S26.CrossRefPubMed
10.
go back to reference Dieye TN, Diaw PA, Daneau G, Wade D, Niang MS, Camara M, Diallo AA, Kane CT, Ndiaye HD, Mbengue B, Dieye A, Kestens L, Mboup S: Evaluation of a flow cytometry method for CD4 T cell enumeration based on volumetric primary CD4 gating using thrermoresistant reagents. J Immunol Methods. 2011, 372: 7-13. 10.1016/j.jim.2011.07.012.CrossRefPubMed Dieye TN, Diaw PA, Daneau G, Wade D, Niang MS, Camara M, Diallo AA, Kane CT, Ndiaye HD, Mbengue B, Dieye A, Kestens L, Mboup S: Evaluation of a flow cytometry method for CD4 T cell enumeration based on volumetric primary CD4 gating using thrermoresistant reagents. J Immunol Methods. 2011, 372: 7-13. 10.1016/j.jim.2011.07.012.CrossRefPubMed
11.
go back to reference Barbesti S, Soldini L, Carcelain G, Guignet A, Colizzi V, Mantelli B, Corvaglia A, Tran-Minh T, Dorigatti F, Autran B, Lazzarin A, Beretta A: A simplified flow cytometry method of CD4 and CD8 cell counting based on thermoresistant reagents: implications for large scale monitoring of HIV-infected patients in resource-limited settings. Cytometry B Clin Cytom. 2005, 68: 43-51.CrossRefPubMed Barbesti S, Soldini L, Carcelain G, Guignet A, Colizzi V, Mantelli B, Corvaglia A, Tran-Minh T, Dorigatti F, Autran B, Lazzarin A, Beretta A: A simplified flow cytometry method of CD4 and CD8 cell counting based on thermoresistant reagents: implications for large scale monitoring of HIV-infected patients in resource-limited settings. Cytometry B Clin Cytom. 2005, 68: 43-51.CrossRefPubMed
13.
go back to reference Taiwo BO, Murphy RL: Clinical applications and availability of CD4 T cell count testing in sub-Saharan Africa. Cytometry B Clin Cytom. 2008, 74B (Suppl 1): S11-S18.CrossRef Taiwo BO, Murphy RL: Clinical applications and availability of CD4 T cell count testing in sub-Saharan Africa. Cytometry B Clin Cytom. 2008, 74B (Suppl 1): S11-S18.CrossRef
14.
go back to reference Larsen CH: The fragile environments of inexpensive CD4 T-cell enumeration in the least developed countries: strategies for accessible support. Cytometry B Clin Cytom. 2008, 74B (Suppl 1): S107-S116.CrossRef Larsen CH: The fragile environments of inexpensive CD4 T-cell enumeration in the least developed countries: strategies for accessible support. Cytometry B Clin Cytom. 2008, 74B (Suppl 1): S107-S116.CrossRef
15.
go back to reference Mbopi-Kéou FX, Ongolo-Zogo P, Angwafo F, Ndumbe PM, Bélec L: High impact of mobile units for mass HIV testing in Africa. AIDS. 2007, 21: 1994-1996. 10.1097/QAD.0b013e3282f006c3.CrossRefPubMed Mbopi-Kéou FX, Ongolo-Zogo P, Angwafo F, Ndumbe PM, Bélec L: High impact of mobile units for mass HIV testing in Africa. AIDS. 2007, 21: 1994-1996. 10.1097/QAD.0b013e3282f006c3.CrossRefPubMed
16.
go back to reference O'Connor CA, Patsdaughter CA, Grindel CG, Taveira PF, Steinberg JL: A mobile HIV education and testing program: bringing services to hard-to-reach populations. AIDS Patient Care STDS. 1998, 12: 931-937. 10.1089/apc.1998.12.931.CrossRefPubMed O'Connor CA, Patsdaughter CA, Grindel CG, Taveira PF, Steinberg JL: A mobile HIV education and testing program: bringing services to hard-to-reach populations. AIDS Patient Care STDS. 1998, 12: 931-937. 10.1089/apc.1998.12.931.CrossRefPubMed
17.
go back to reference Vidal L: Disclosure and counselling: elements for a review of the literature about African experiences [in French]. Psychopathol Africaine. 1994, XXVI: 155-188. Vidal L: Disclosure and counselling: elements for a review of the literature about African experiences [in French]. Psychopathol Africaine. 1994, XXVI: 155-188.
18.
go back to reference Kranzer K, Wood R, Bekker LG: Earlier HIV diagnosis--are mobile services the answer?. S Afr Med J. 2010, 100: 671-674.CrossRefPubMed Kranzer K, Wood R, Bekker LG: Earlier HIV diagnosis--are mobile services the answer?. S Afr Med J. 2010, 100: 671-674.CrossRefPubMed
19.
go back to reference Grabbe KL, Menzies N, Taegtmeyer M, Emukule G, Angala P, Mwega I, Musango G, Marum E: Increasing access to HIV counseling and testing through mobile services in Kenya: strategies, utilization, and cost-effectiveness. J Acquir Immune Defic Syndr. 2010, 54: 317-323. 10.1097/QAI.0b013e3181ced126.CrossRefPubMedPubMedCentral Grabbe KL, Menzies N, Taegtmeyer M, Emukule G, Angala P, Mwega I, Musango G, Marum E: Increasing access to HIV counseling and testing through mobile services in Kenya: strategies, utilization, and cost-effectiveness. J Acquir Immune Defic Syndr. 2010, 54: 317-323. 10.1097/QAI.0b013e3181ced126.CrossRefPubMedPubMedCentral
20.
go back to reference Hoffman RA, Hansen WP: Simple and rapid measurement of human T lymphocytes and their subclasses in peripheral blood. Proc Natl Acad Sci USA. 1980, 77: 4914-4917. 10.1073/pnas.77.8.4914.CrossRefPubMedPubMedCentral Hoffman RA, Hansen WP: Simple and rapid measurement of human T lymphocytes and their subclasses in peripheral blood. Proc Natl Acad Sci USA. 1980, 77: 4914-4917. 10.1073/pnas.77.8.4914.CrossRefPubMedPubMedCentral
21.
go back to reference Brando B, Barnett D, Janossy G, Mandy F, Autran B, Rothe G, Scarpati B, D'Avanzo G, D'Hautcourt JL, Lenkei R, Schmitz G, Kunkl A, Chianese R, Papa S, Gratama JW: Cytofluorometric methods for assessing absolute numbers of cell subsets in blood. Cytometry. 2000, 42: 327-346. 10.1002/1097-0320(20001215)42:6<327::AID-CYTO1000>3.0.CO;2-F.CrossRefPubMed Brando B, Barnett D, Janossy G, Mandy F, Autran B, Rothe G, Scarpati B, D'Avanzo G, D'Hautcourt JL, Lenkei R, Schmitz G, Kunkl A, Chianese R, Papa S, Gratama JW: Cytofluorometric methods for assessing absolute numbers of cell subsets in blood. Cytometry. 2000, 42: 327-346. 10.1002/1097-0320(20001215)42:6<327::AID-CYTO1000>3.0.CO;2-F.CrossRefPubMed
22.
go back to reference Mercolino TJ, Connelly MC, Meyer EJ, Knight MD, Parker JW, Stelzer GT, DeChirico G: Immunologic differentiation of absolute lymphocyte count with an integrated flow cytometric system: a new concept for absolute T cell subset determination. Cytometry. 1995, 22: 48-59. 10.1002/cyto.990220110.CrossRefPubMed Mercolino TJ, Connelly MC, Meyer EJ, Knight MD, Parker JW, Stelzer GT, DeChirico G: Immunologic differentiation of absolute lymphocyte count with an integrated flow cytometric system: a new concept for absolute T cell subset determination. Cytometry. 1995, 22: 48-59. 10.1002/cyto.990220110.CrossRefPubMed
23.
go back to reference Passing H, Bablok W: A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry, Part I. J Clin Chem Clin Biochem. 1983, 21: 709-720.PubMed Passing H, Bablok W: A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry, Part I. J Clin Chem Clin Biochem. 1983, 21: 709-720.PubMed
24.
go back to reference Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986, 1: 307-310.CrossRefPubMed Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986, 1: 307-310.CrossRefPubMed
25.
go back to reference Bland JM, Altman DG: Measuring agreement in method comparison studies. Stat Methods Med Res. 1999, 8: 135-160. 10.1191/096228099673819272.CrossRefPubMed Bland JM, Altman DG: Measuring agreement in method comparison studies. Stat Methods Med Res. 1999, 8: 135-160. 10.1191/096228099673819272.CrossRefPubMed
27.
go back to reference Cohen J: A coefficient of agreement for nominal scales. Educ Psychol Meas. 1960, 20: 37-46. 10.1177/001316446002000104.CrossRef Cohen J: A coefficient of agreement for nominal scales. Educ Psychol Meas. 1960, 20: 37-46. 10.1177/001316446002000104.CrossRef
28.
go back to reference Fredlund VG, Nash J: How far should they walk? Increasing antiretroviral therapy access in a rural community in northern KwaZulu-Natal, South Africa. J Infect Dis. 2007, 196 (Suppl 3): S469-S473.CrossRefPubMed Fredlund VG, Nash J: How far should they walk? Increasing antiretroviral therapy access in a rural community in northern KwaZulu-Natal, South Africa. J Infect Dis. 2007, 196 (Suppl 3): S469-S473.CrossRefPubMed
29.
go back to reference Loubiere S, Boyer S, Protopopescu C, Bonono CR, Abega SC, Spire B, Moatti JP: Decentralization of HIV care in Cameroon: increased access to antiretroviral treatment and associated persistent barriers. Health Policy. 2009, 92: 165-173. 10.1016/j.healthpol.2009.03.006.CrossRefPubMed Loubiere S, Boyer S, Protopopescu C, Bonono CR, Abega SC, Spire B, Moatti JP: Decentralization of HIV care in Cameroon: increased access to antiretroviral treatment and associated persistent barriers. Health Policy. 2009, 92: 165-173. 10.1016/j.healthpol.2009.03.006.CrossRefPubMed
30.
go back to reference Wools-Kaloustian KK, Sidle JE, Selke HM, Vedanthan R, Kemboi EK, Boit LJ, Jebet VT, Carroll AE, Tierney WM, Kimaiyo S: A model for extending antiretroviral care beyond the rural health centre. J Int AIDS Soc. 2009, 12: 22-10.1186/1758-2652-12-22.CrossRefPubMedPubMedCentral Wools-Kaloustian KK, Sidle JE, Selke HM, Vedanthan R, Kemboi EK, Boit LJ, Jebet VT, Carroll AE, Tierney WM, Kimaiyo S: A model for extending antiretroviral care beyond the rural health centre. J Int AIDS Soc. 2009, 12: 22-10.1186/1758-2652-12-22.CrossRefPubMedPubMedCentral
31.
go back to reference Rosen S, Fox MP, Gill CJ: Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoSMed. 2007, 4: e298- Rosen S, Fox MP, Gill CJ: Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoSMed. 2007, 4: e298-
32.
go back to reference Bedelu M, Ford N, Hilderbrand K, Reuter H: Implementing antiretroviral therapy in rural communities: the Lusikisiki model of decentralized HIV/AIDS care. J Infect Dis. 2007, 196 (Suppl 3): S464-S468.CrossRefPubMed Bedelu M, Ford N, Hilderbrand K, Reuter H: Implementing antiretroviral therapy in rural communities: the Lusikisiki model of decentralized HIV/AIDS care. J Infect Dis. 2007, 196 (Suppl 3): S464-S468.CrossRefPubMed
33.
go back to reference Boyer S, Eboko F, Camara M, Abé C, Nguini ME, Koulla-Shiro S, Moatti JP: Scaling up access to antiretroviral treatment for HIV infection: the impact of decentralization of healthcare delivery in Cameroon. AIDS. 2010, 24: S5-S15.CrossRefPubMed Boyer S, Eboko F, Camara M, Abé C, Nguini ME, Koulla-Shiro S, Moatti JP: Scaling up access to antiretroviral treatment for HIV infection: the impact of decentralization of healthcare delivery in Cameroon. AIDS. 2010, 24: S5-S15.CrossRefPubMed
34.
go back to reference Chan AK, Mateyu G, Jahn A, Schouten E, Arora P, Mlotha W, Kambanji M, van Lettow M: Outcome assessment of decentralization of antiretroviral therapy provision in a rural district of Malawi using an integrated primary care model. Trop Med Int Health. 2010, 15 (Suppl 1): 90-97.CrossRefPubMed Chan AK, Mateyu G, Jahn A, Schouten E, Arora P, Mlotha W, Kambanji M, van Lettow M: Outcome assessment of decentralization of antiretroviral therapy provision in a rural district of Malawi using an integrated primary care model. Trop Med Int Health. 2010, 15 (Suppl 1): 90-97.CrossRefPubMed
35.
go back to reference Fatti G, Grimwood A, Bock P: Better antiretroviral therapy outcomes at primary healthcare facilities: an evaluation of three tiers of ART services in four South African provinces. PLoS One. 2010, 5: e12888-10.1371/journal.pone.0012888.CrossRefPubMedPubMedCentral Fatti G, Grimwood A, Bock P: Better antiretroviral therapy outcomes at primary healthcare facilities: an evaluation of three tiers of ART services in four South African provinces. PLoS One. 2010, 5: e12888-10.1371/journal.pone.0012888.CrossRefPubMedPubMedCentral
36.
go back to reference Geng EH, Nash D, Kambugu A, Zhang Y, Braitstein P, Christopoulos KA, Muyindike W, Bwana MB, Yiannoutsos CT, Petersen ML, Martin JN: Retention in care among HIV infected patients in resource-limited settings: emerging insights and new directions. Curr HIV/AIDS Rep. 2010, 7: 234-244. 10.1007/s11904-010-0061-5.CrossRefPubMedPubMedCentral Geng EH, Nash D, Kambugu A, Zhang Y, Braitstein P, Christopoulos KA, Muyindike W, Bwana MB, Yiannoutsos CT, Petersen ML, Martin JN: Retention in care among HIV infected patients in resource-limited settings: emerging insights and new directions. Curr HIV/AIDS Rep. 2010, 7: 234-244. 10.1007/s11904-010-0061-5.CrossRefPubMedPubMedCentral
38.
go back to reference Hardon AP, Akurut D, Comoro C, Ekezie C, Irunde HF, Gerrits T, Kglatwane J, Kinsman J, Kwasa R, Maridadi J, Moroka TM, Moyo S, Nakiyemba A, Nsimba S, Ogenyi R, Oyabba T, Temu F, Laing R: Hunger, waiting time and transport costs: time to confront challenges to ART adherence in Africa. AIDS Care. 2007, 19: 658-665. 10.1080/09540120701244943.CrossRefPubMed Hardon AP, Akurut D, Comoro C, Ekezie C, Irunde HF, Gerrits T, Kglatwane J, Kinsman J, Kwasa R, Maridadi J, Moroka TM, Moyo S, Nakiyemba A, Nsimba S, Ogenyi R, Oyabba T, Temu F, Laing R: Hunger, waiting time and transport costs: time to confront challenges to ART adherence in Africa. AIDS Care. 2007, 19: 658-665. 10.1080/09540120701244943.CrossRefPubMed
39.
go back to reference Miller CM, Ketlhapile M, Rybasack-Smith H, Rosen S: Why are antiretroviral treatment patients lost to follow-up? A qualitative study from South Africa. Trop Med Int Health. 2010, 15 (Suppl 1): 48-54.CrossRefPubMedPubMedCentral Miller CM, Ketlhapile M, Rybasack-Smith H, Rosen S: Why are antiretroviral treatment patients lost to follow-up? A qualitative study from South Africa. Trop Med Int Health. 2010, 15 (Suppl 1): 48-54.CrossRefPubMedPubMedCentral
41.
go back to reference Jani IV, Sitoe NE, Chongo PL, Alfai ER, Quevedo JI, Tobaiwa O, Lehe JD, Peter TF: Accurate CD4 T-cell enumeration and antiretroviral drug toxicity monitoring in primary healthcare clinics using point-of-care testing. AIDS. 2011, 25: 807-812. 10.1097/QAD.0b013e328344f424.CrossRefPubMed Jani IV, Sitoe NE, Chongo PL, Alfai ER, Quevedo JI, Tobaiwa O, Lehe JD, Peter TF: Accurate CD4 T-cell enumeration and antiretroviral drug toxicity monitoring in primary healthcare clinics using point-of-care testing. AIDS. 2011, 25: 807-812. 10.1097/QAD.0b013e328344f424.CrossRefPubMed
42.
go back to reference Dube C, Nozaki I, Hayakawa T, Kakimoto K, Yamada N, Simpungwe JB: Expansion of antiretroviral treatment to rural health centre level by a mobile service in Mumbwa district, Zambia. Bull World Health Organ. 2010, 88: 788-791. 10.2471/BLT.09.063982.CrossRefPubMedPubMedCentral Dube C, Nozaki I, Hayakawa T, Kakimoto K, Yamada N, Simpungwe JB: Expansion of antiretroviral treatment to rural health centre level by a mobile service in Mumbwa district, Zambia. Bull World Health Organ. 2010, 88: 788-791. 10.2471/BLT.09.063982.CrossRefPubMedPubMedCentral
43.
go back to reference Goldie SJ, Yazdanpanah Y, Losina E, Weinstein MC, Anglaret X, Walensky RP, Hsu HE, Kimmel A, Holmes C, Kaplan JE, Freedberg KA: Cost-effectiveness of HIV treatment in resource-poor settings: the case of Cote d'Ivoire. N Engl J Med. 2006, 355: 1141-1153. 10.1056/NEJMsa060247.CrossRefPubMed Goldie SJ, Yazdanpanah Y, Losina E, Weinstein MC, Anglaret X, Walensky RP, Hsu HE, Kimmel A, Holmes C, Kaplan JE, Freedberg KA: Cost-effectiveness of HIV treatment in resource-poor settings: the case of Cote d'Ivoire. N Engl J Med. 2006, 355: 1141-1153. 10.1056/NEJMsa060247.CrossRefPubMed
44.
go back to reference Loubiere S, Meiners C, Sloan C, Freedberg KA, Yazdanpanah Y: Economic evaluation of ART in resource-limited countries. Curr Opin HIV AIDS. 2010, 5: 225-231. 10.1097/COH.0b013e3283384a9d.CrossRefPubMedPubMedCentral Loubiere S, Meiners C, Sloan C, Freedberg KA, Yazdanpanah Y: Economic evaluation of ART in resource-limited countries. Curr Opin HIV AIDS. 2010, 5: 225-231. 10.1097/COH.0b013e3283384a9d.CrossRefPubMedPubMedCentral
45.
go back to reference Walensky P, Ciaranello CL, Park J-E, Freedberg KA: Cost-effectiveness of laboratory monitoring in sub-Saharan Africa: A review of the current literature. Clin Infect Dis. 2010, 51: 85-82. 10.1086/653119.CrossRefPubMedPubMedCentral Walensky P, Ciaranello CL, Park J-E, Freedberg KA: Cost-effectiveness of laboratory monitoring in sub-Saharan Africa: A review of the current literature. Clin Infect Dis. 2010, 51: 85-82. 10.1086/653119.CrossRefPubMedPubMedCentral
46.
go back to reference DiFranceisco W, Holtgrave DR, Hoxie N, Reiser WJ, Resenhoeft R, Pinkerton SD, Vergeront J: HIV seropositivity rates in outreach-based counseling and testing services: program evaluation. J Acquir Immune Defic Syndr Hum Retrovirol. 1998, 19: 282-288. 10.1097/00042560-199811010-00011.CrossRefPubMed DiFranceisco W, Holtgrave DR, Hoxie N, Reiser WJ, Resenhoeft R, Pinkerton SD, Vergeront J: HIV seropositivity rates in outreach-based counseling and testing services: program evaluation. J Acquir Immune Defic Syndr Hum Retrovirol. 1998, 19: 282-288. 10.1097/00042560-199811010-00011.CrossRefPubMed
47.
go back to reference Ellen JM, Bonu S, Arruda JS, Ward MA, Vogel R: Comparison of clients of a mobile health van and a traditional STD clinic. J Acquir Immune Defic Syndr. 2003, 32: 388-393. 10.1097/00126334-200304010-00007.CrossRefPubMed Ellen JM, Bonu S, Arruda JS, Ward MA, Vogel R: Comparison of clients of a mobile health van and a traditional STD clinic. J Acquir Immune Defic Syndr. 2003, 32: 388-393. 10.1097/00126334-200304010-00007.CrossRefPubMed
48.
go back to reference Babigumira JB, Sethi AK, Smyth KA, Singer ME: Cost effectiveness of facility-based care, home-based care and mobile clinics for provision of antiretroviral therapy in Uganda. Pharmacoeconomics. 2009, 27: 963-973. 10.2165/11318230-000000000-00000.CrossRefPubMedPubMedCentral Babigumira JB, Sethi AK, Smyth KA, Singer ME: Cost effectiveness of facility-based care, home-based care and mobile clinics for provision of antiretroviral therapy in Uganda. Pharmacoeconomics. 2009, 27: 963-973. 10.2165/11318230-000000000-00000.CrossRefPubMedPubMedCentral
Metadata
Title
Validation of a single-platform, volumetric, flow cytometry for CD4 T cell count monitoring in therapeutic mobile unit
Authors
François-Xavier Mbopi-Kéou
Bertrand Sagnia
Jeanne Ngogang
Fru F Angwafo III
Vittorio Colizzi
Luc Montagnier
Laurent Bélec
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2012
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/1479-5876-10-22

Other articles of this Issue 1/2012

Journal of Translational Medicine 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.